// App-Quantinova.ai

: Efficacy of inhaled dry powder tobramycin (TOBI Podhaler in P. aeruginosa infected patients with bronchiectasis - iBEST study

Researchers

Presenter

  • Michael Loebinger

Principal Investigators

  • Eva Polverino

  • Francesco Blasi

  • Stuart Elborn

  • James Chalmers

  • Harm Tiddens

  • Herman Goossens

  • Michael Tunney

  • Felix Ringshausen

  • Adam Hill

  • Rashidkhan Pathan

  • Gerhild Angyalosi

  • Charles Haworth

Medical Centers

  • Host Defence Unit, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, United Kingdom

  • Respiratory Disease Department, Vall d’ Hebron University Hospital – VHIR, Barcelona, Spain

  • Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

  • Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom

  • Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Dundee, United Kingdom

  • Dept. of Pediatrics, Pediatric Pulmonology & Allergology, Erasmus Medical Center- Sophia Children’s Hospital, Rotterdam, Netherlands

  • Department of Clinical Pathology, University Hospital Antwerp, Antwerp, Belgium

  • Halo Research Group, School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom

  • Institute for Pathology, Hannover Medical School, Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany

  • Department of Respiratory Medicine, Royal Infirmary and University of Edinburgh, Edinburgh, United Kingdom,

  • Novartis Healthcare Pvt. Ltd, Hyderabad, India

  • Novartis AG, Basel, Switzerland

  • Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, United Kingdom

Locations

  • United Kingdom

  • Spain

  • Italy

  • Netherlands

  • Belgium

  • Germany

  • India

  • Switzerland

Companies

  • Novartis AG

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • TOBI Podhaler

  • Tobramycin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved